Annual Revenue (£)

GlaxoSmithKline revenue was £30.19 b in FY, 2017 which is a 8.2% year over year increase from the previous period.

Quarterly Revenue (£)

FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2016FY, 2017
Revenue£18.08 b£20.49 b£21.21 b£21.44 b£20.36 b£21.66 b£23.22 b£22.72 b£26.51 b£27.89 b£30.19 b
Growth16.58%8.24%
Q1, 2017Q2, 2017Q3, 2017Q1, 2018
Revenue£7.38 b£7.32 b£7.84 b£7.22 b
Report incorrect company information

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

GlaxoSmithKline revenue breakdown by business segment: 25.7% from Consumer Healthcare, 17.1% from Vaccines and 57.2% from Global Pharmaceuticals

GlaxoSmithKline revenue breakdown by geographic segment: 59.6% from International, 37.3% from US and 3.1% from Other

FY, 2016FY, 2017
Global Pharmaceuticals16.10 b17.28 b
Vaccines4.60 b5.16 b
Consumer Healthcare7.20 b7.75 b
FY, 2016FY, 2017
International16.64 b17.98 b
US10.20 b11.26 b
UK1.06 b940 m
Report incorrect company information